Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study

INTRODUCTION: Mortality and disability in diabetes mellitus are determined mostly by cardiovascular complications and cancer. The impact of dipeptidyl peptidase-4 inhibitor (DPP-4i) and sodium-glucose cotransporter-2 inhibitor (SGLT2i) monotherapy or combination on long-term complications of type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Sütő, Gábor, Molnár, Gergő A, Rokszin, Gyorgy, Fábián, Ibolya, Kiss, Zoltan, Szekanecz, Zoltán, Poór, Gyula, Jermendy, György, Kempler, Peter, Wittmann, István
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Epidemiology/Health services research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818813/
https://www.ncbi.nlm.nih.gov/pubmed/33472796
http://dx.doi.org/10.1136/bmjdrc-2020-001765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818813/
https://www.ncbi.nlm.nih.gov/pubmed/33472796
http://dx.doi.org/10.1136/bmjdrc-2020-001765

Ejemplares similares